Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease

Journal of Lipid Research

Volumn 45, Issue 1, 2004, Pages 186-193

  Heverin, Maura ^a   Bogdanovic, Nenad ^a   Lütjohann, Dieter ^b   Bayer, Thomas ^c   Pikuleva, Irina ^d   Bretillon, Lionel ^a,e   Diczfalusy, Ulf ^a   Winblad, Bengt ^a   Björkhem, Ingemar ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF BONN   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

^d University of Texas Medical Branch School of Medicine   (United States)

^e CEMAGREF   (France)

Author keywords

Cerebral cholesterol; Cholesterol 24S hydroxylase; Oxysterols; Sterol 27 hydroxylase

Indexed keywords

24 HYDROXYCHOLESTEROL; 26 HYDROXYCHOLESTEROL; CHOLESTEROL; LATHOSTEROL; OXYSTEROL; PHYTOSTEROL; STEROL; UNCLASSIFIED DRUG;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN REGION; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FRONTAL CORTEX; GENE MUTATION; HUMAN; HUMAN TISSUE; LIPID BRAIN LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; FEMALE; HUMANS; HYDROXYCHOLESTEROLS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; MIXED FUNCTION OXYGENASES; WATER;

EID: 0842303768     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300320-JLR200     Document Type: Article

References (38)

1. Puglielli, L., R. E. Tanzi, and D. M. Kovacs. 2003. Alzheimer's disease: the cholesterol connection. Nat. Neurosci. 6: 345-351.
2. Strittmatter, W. J., A. M. Saunders, D. Schmechel, M. Pericak Vance, J. Enghild, S. Salvesen, and A. D. Roses. 1993. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of Type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. USA. 90: 1977-1981.
3. Simons, M., P. Keller, B. De Strooper, K. Beyreuther, C. G. Dotti, and K. Simons. 1998. Cholesterol depletion inhibits the generation of β-amyloid in hippocampal regions. Proc. Natl. Acad. Sci. USA. 95: 6460-6464.
4. Howland, D. S., S. P. Trusko, M. J. Savage, A. G. Reaume, D. M. Lang, J. D. Hirsch, N. Maeda, R. Siman, B. D. Greenberg, R. W. Scott, and D. G. Flood. 1998. Modulation of secreted β-amyloid precursor protein and amyloid β-peptide by cholesterol. J. Biol. Chem. 273: 16576-16582.
5. Refolo, L. M., M. A. Pappolla, B. Malester, J. LaFrancois, T. Bryant-Thomas, R. Wang, G. S. Tint, K. Sambamurti, and K. Duff. 2000. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol. Dis. 7: 321-331.
6. Wolozin, B., W. Kellman, and P. Ruosseau. 2000. Decreased prevalence of Alzheimer disease associated with HMG CoA reductase inhibitors. Arch. Neurol. 57: 1439-1443.
7. Jick, H., G. L. Zornberg, S. Jick, S. Seshadri, and A. Drachman. 2000. Statins and the risk of dementia. Lancet. 356: 1627-1631.
8. Buxbaum, J. D., E. I. Cullen, and L. T. Friedhoff. 2002. Pharmacological concentrations of the HMG CoA reductase inhibitor lovastatin decrease the formation of the Alzheimer beta-amyloid peptide in vitro and in patients. Front. Biosci. 7: 50-59.
9. Dietschy, J. M., and S. D. Turley. 2001. Cholesterol metabolism in the brain. Curr. Opin. Lipidol. 12: 105-112.
10. Snipes, G. J., and U. Suter. 1997. Cholesterol and myelin. In Subcellular Biochemistry. Vol. 28. R. Bittman, editor. Plenum Press, New York. 173-204.
11. Lütjohann, D., O. Breuer, G. Ahlborg, I. Nennesmo, Å. Sidén, U. Diczfalusy, and I. Björkhem. 1996. Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. USA. 93: 9799-9804.
12. Björkhem, I., D. Lütjohann, O. Breuer, A. Sakinis, and A. Wennmalm. 1997. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with 18O2 techniques in vivo and in vitro. J. Biol. Chem. 272: 30178-30184.
13. Björkhem, I., D. Lütjohann, U. Diczfalusy, L. Ståhle, G. Ahlborg, and J. Wahren. 1998. Cholesterol homeostasis in the human brain: turnover of 24S-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res. 39: 1594-1600.
14. Lund, E. G., J. M. Guileyardo, and D. W. Russell. 1999. cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. USA. 16: 7238-7243.
15. Bretillon, L., Å. Sidén, L-O. Wahlund, D. Lütjohann, L. Minthon, M. Crisby, J. Hillert, C-G. Groth, U. Diczfalusy, and I. Björkhem. 2000. Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases. Neurosci. Lett. 293: 87-90.
16. Lütjohann, D., A. Papassotiropoulos, I. Björkhem, S. Locatelli, M. Bagli, M. L. Rao, K. von Bergmann, and R. Heun. 2000. 24S-hydroxycholesterol (cerebrosterol) and Alzheimer's disease. J. Lipid Res. 41: 195-198.
17. Bogdanovic, N., L. Bretillon, E. Lund, U. Diczfalusy, L. Lannfelt, B. Winblad, D. Russell, and I. Björkhem. 2001. On the turnover of brain cholesterol in patients with Alzheimer's disease. Abnormal induction of the cholesterol-catabolic enzyme CYP46 in glial cells. Neurosci. Lett. 314: 45-48.
18. Lütjohann, D., A. Brzezinka, E. Barth, D. Abramowski, M. Staufenbiel, K. von Bergmann, K. Beyreuther, G. Multhaup, and T. A. Bayer. 2002. Profile of cholesterol-related sterols in aged amyloid precursor protein transgenic mouse brain. J. Lipid Res. 43: 1078-1085.
19. Blennow, K., A. Wallin, P. Fredman, I. Karlsson, C. G. Gottfries, and L. Svennerholm. 1990. Blood brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol Scand. 81: 323-326.
20. McKhann, G., D. Drachman, M. Folstein, R. Katzman, D. Price, and E. M. Stadlan. 1984. Clinical diagnosis of Alzheimer disease. Neurology. 34: 939-944.
21. Lund, E., O. Andersson, J. Zhang, A. Babiker, G. Ahlborg, U. Diczfalusy, K. Einarsson, J. Sjövall, and I. Björkhem. 1996. Importance of a novel oxidative mechanism for elimination of intracellular cholesterol in humans. Arterioscler. Thromb. Vasc. Biol. 16: 208-212.
22. Leoni, M., T. Masterman, P. Patel, S. Meaney, U. Diczfalusy, and I. Björkhem. 2003. Side-chain oxidized oxysterols in cerebrospinal fluid and integrity of the blood-brain barrier. J. Lipid Res. 44: 793-799.
23. Björkhem, I., U. Diczfalusy, and D. Lütjohann. 1999. Removal of cholesterol from extrahepatic sources by oxidative mechanisms. Curr. Opin. Lipidol. 10: 161-165.
24. Mirra, S. S., A. Heyman, D. McKeel, S. M. Sumi, B. J. Crain, L. M. Brownlee, F. S. Vogel, J. P. Hughes, G. van Belle, and L. Berg. 1991. The consortium to establish a register for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology. 41: 479-486.
25. Bogdanovic, N., and J. H. Morris. 1995. Diagnostic criteria for Alzheimer's disease in multicentre brain banking. In Neuropathological Diagnostic Criteria for Brain Banking. F. F. Cruz-Sanchez, R. Ravid, and M. L. Cuzner, editors. Biomedical and Health Research Series. IOS Press, Amsterdam, The Netherlands. 20-29.
26. Björkhem, I., R. Blomstrand, and L. Svensson. 1974. Determinations of cholesterol by mass fragmentography. Clin. Chim. Acta. 54: 185-193.
27. Lund, E., L. Sisfontes, E. Reihner, and I. Björkhem. 1989. Determination of serum levels of unesterified lathosterol by isotope dilution-mass spectrometry. Scand. J. Clin. Lab. Invest. 49: 165-171.
28. Dzeletovic, S., O. Breuer, E. G. Lund, and U. Diczfalusy. 1995. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225: 73-80.
29. Cali, J. J., C. L. Hsieh, U. Francke, and D. W. Russell. 1991. Mutations in the bile acid biosynthetic enzyme sterol 27-hydroxylase underlie cerebrotendinous xanthomatosis. J. Biol. Chem. 266: 7779-7783.
30. Wood, W. G., F. Schroeder, N. A. Adulov, S. V. Chochina, and U. Igbavboda. 1999. Recent advances in cholesterol dynamics: transport, domains and Alzheimer disease. Lipids. 34: 225-234.
31. Poduslo, J. F., G. L. Curran, T M. Wengenack, B. Malester, and K. Duff. 2001. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse of Alzheimer's disease. Neurobiol. Dis. 8: 555-567.
32. Babiker, A., O. Andersson, D. Lindblom, J. van der Linden, B. Wiklund, D. Lütjohann, U. Diczfalusy, and I. Björkhem. 1999. Elimination of cholesterol as cholestenoic acid in human lung by sterol 27-hydroxylase: evidence that most of this steroid in the circulation is of pulmonary origin. J. Lipid Res. 40: 1417-1425.
33. Meaney, S., K. Bodin, U. Diczfalusy, and I. Björkhem. 2003. On the rate of translocation in vitro and kinetics in vivo of the major oxysterols in human circulation: critical importance of the position of the oxygen function. J. Lipid Res. 44: 2130-2135.
34. Lehmann, J. M., S. A. Kliewer, L. B. Moore, T. A. Smith-Oliver, B. B. Oliver, J-L. Su, S. S. Sundseth, D. A. Winegar, D. E. Blanchard, T. A. Spencer, and T. B. Willson. 1997. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J. Biol. Chem. 272: 3137-3140.
35. Whitney, K. D., M. A. Watson, J. L. Collins, W. G. Benson, T. M. Stone, M. J. Numerick, T. K. Tippin, J. G. Wilson, D. A. Winegar, and S. A. Kliewer. 2002. Regulation of cholesterol homeostasis by the liver X receptors in the central nervous system. Mol. Endocrinol. 16: 1378-1385.
36. Wang, L., G. Schuster, K. Hultenby, Q. Zhang, S. Andersson, and J-Å. Gustafsson. 2002. Liver X receptors in the central nervous system: from lipid homeostasis to neuronal degeneration. Proc. Natl. Acad. Sci. USA. 99: 13878-13883.
37. Lund, E. G., C. Xie, T. Kotti, S. D. Turley, J. M. Dietschy, and D. W. Russell. 2003. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J. Biol. Chem. 278: 22980-22988.
38. Simmonds, M. A. 2002. The emerging neurobiology of cholesterol. Neurobiol. Lipids. 1: 1-4.